bioSyntagma

Predictive analytics and biomarker discovery for treating cancer

David Richardson - Co-Founder and CEO, Dmitry Derkach MD, PhD - Chief Science Officer, Colleen Ziegler - Co-Founder, Director of Operations
employees
$1,200,000 funding,
2015